Crinetics Pharmaceuticals, Inc. Share-based Payment Arrangement, Expensed and Capitalized, Amount
Crinetics Pharmaceuticals, Inc. (CRNX) reported Share-based Payment Arrangement, Expensed and Capitalized, Amount of $24.95 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Expensed and Capitalized, Amount
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1 · last filed 2026-08-03
- Crinetics Pharmaceuticals, Inc. share-based payment arrangement, expensed and capitalized, amount for the quarter ending 2026-06-30 was $24.95M, a 4.51% decline year-over-year.
- Crinetics Pharmaceuticals, Inc. share-based payment arrangement, expensed and capitalized, amount for the quarter ending 2026-03-31 was $29.81M, a 45.59% increase year-over-year.
- Crinetics Pharmaceuticals, Inc. share-based payment arrangement, expensed and capitalized, amount for the quarter ending 2025-06-30 was $26.12M.
- Crinetics Pharmaceuticals, Inc. share-based payment arrangement, expensed and capitalized, amount for the quarter ending 2025-03-31 was $20.48M.
| Period end | Share-based Payment Arrangement, Expensed and Capitalized, Amount 3 month | Share-based Payment Arrangement, Expensed and Capitalized, Amount 6 month |
|---|---|---|
| 2026-06-30 | $24.95M 10-Q · filed 2026-08-03 | $54.76M 10-Q · filed 2026-08-03 |
| 2026-03-31 | $29.81M 10-Q · filed 2026-05-07 | |
| 2025-06-30 | $26.12M 10-Q · filed 2026-08-03 | $46.60M 10-Q · filed 2026-08-03 |
| 2025-03-31 | $20.48M 10-Q · filed 2026-05-07 |